Mictonorm Uno (Propiverine Hydrochloride)

Propiverine works by blocking muscarinic (M2 and M3) receptors in the detrusor smooth muscle of the bladder, which reduces involuntary contractions. Its additional calcium‑channel blocking activity further relaxes the bladder wall, decreasing urgency and frequency of urination.

The dosage of Mictonorm Uno is individualized. A qualified prescriber determines the appropriate strength and dosing schedule based on the patient’s condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.

Safety of propiverine during pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the prescribing clinician.

To place an order, submit an enquiry on the Mictonorm Uno product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The most common alternative to propiverine is oxybutynin, another antimuscarinic. Propiverine often provides comparable bladder‑control benefits but may have a lower incidence of dry mouth for some patients due to its additional calcium‑channel blocking effect. Choice between agents depends on individual response, side‑effect profile, and physician preference.

Mictonorm Uno should be stored at room temperature below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Mictonorm Uno is taken orally, usually with a glass of water. The tablet is swallowed whole and should be taken as directed by the prescribing clinician, with or without food depending on the specific instructions provided.

Serious adverse events include acute urinary retention, which may require immediate medical attention, and severe allergic reactions such as anaphylaxis. Patients should seek urgent care if they experience inability to urinate, swelling of the face or throat, or difficulty breathing.

Mictonorm Uno is contraindicated in patients with urinary retention, uncontrolled narrow‑angle glaucoma, severe hepatic impairment, or known hypersensitivity to propiverine or any excipients. It should also be used with caution in the elderly and in individuals with significant renal dysfunction.